The Health Insurance Rebound That May Not Be What It Seems
Health insurers just reported a strong quarter, but don’t pop the champagne yet. UnitedHealth, Elevance, Cigna, and Humana all topped quarterly estimates, with some even raising full-year outlooks. The results come after rising medical costs battered the industry for years — making the beat feel more impactful than it is.
- Barclays attributed the outperformance to a milder flu season and weather disruptions that kept claims unusually low — not a structural improvement.
- Against that backdrop, said it will cut prior authorization reviews by 30% — easing access to care in an AI-backed move as pressure continues to build.
Read the fine print: The quarter’s results carry another caveat. Insurers work with incomplete claims data early in the year, so cost figures may only reflect January, leaving Q2 as the moment the true bill arrives. Baird flagged Humana as especially exposed, noting that its growth strategy mirrors the playbook CVS ran in 2024, before costs blew past targets. This setup looks good, but in this business of predictability, small moves ironically have a way of carrying outsized impacts.
